logo

Video encyclopedia

30/09/2004 Merck pulls Vioxx, its best-selling drug, for safety reasons

2:21

merck minimized the true risks of vioxx

3:07

Merck recalls blockbuster arthritis drug

2:27

Vioxx and FDA Drug Injuries

3:40

Vioxx - Drugs-Inhibitors - WNBC-TV 4 NY - August 27 2007

Rofecoxib is a nonsteroidal anti-inflammatory drug that has now been withdrawn over safety concerns. It was marketed by Merck & Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhea. Rofecoxib was approved by the U.S. Food and Drug Administration in 1999 and was marketed under the brand names Vioxx, Ceoxx, and Ceeoxx.
    • Essentials 

    • Mode of action 

    • Efficacy 

    • Side effects 

    • Withdrawal 

    • FDA position 

    • Litigation